Adicet Bio Funding & Investors
Adicet Bio, Inc. operates as a clinical-stage bio-pharmaceutical company. The Company designs and develops of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio serves customers worldwide.
adicetbio.comTotal Amount Raised: $145,624,992
Adicet Bio Funding Rounds
Series B
$80,000,000
Series B Investors
Novartis Venture FundRegeneron PharmaceuticalsSamsung VenturesOrbiMed AdvisorsJohnson & Johnson InnovationPontifaxSeries A
$51,000,000
Series A Investors
Novartis Venture FundOrbiMed AdvisorsPontifaxSeries Unknown
$14,625,000
Funding info provided by Diffbot.